CROSS-RESISTANCE ANALYSIS FOR CLINAFLOXACIN COMPARED WITH CIPROFLOXACIN, FLEROXACIN, OFLOXACIN, AND SPARFLOXACIN USING A PREDICTOR PANEL OF CIPROFLOXACIN-RESISTANT BACTERIA

被引:15
作者
CORMICAN, MG
JONES, RN
机构
[1] Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City
关键词
D O I
10.1093/jac/36.2.431
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clinafloxacin was significantly more active against fluoroquinolone-resistant organisms than ciprofloxacin, ofloxacin, sparfloxacin and fleroxacin. Clinafloxacin inhibited 65% of isolates at the recommended breakpoint(less than or equal to 1 mg/L) compared with only 30.0% for ciprofloxacin, 31.7% for ofloxacin, 32% for fleroxacin, and 37.7% for sparfloxacin at their recommended breakpoints. No strain susceptible to ciprofloxacin was resistant to the other compounds tested.
引用
收藏
页码:431 / 434
页数:4
相关论文
共 13 条
[1]  
[Anonymous], 1993, METHODS DILUTION ANT
[2]   ACTIVITY OF CLINAFLOXACIN AGAINST MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM [J].
BURNEY, S ;
LANDMAN, D ;
QUALE, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1668-1670
[3]   CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326
[4]   MULTICENTER EVALUATION OF THE INVITRO ACTIVITIES OF 3 NEW QUINOLONES, SPARFLOXACIN, CI-960, AND PD-131,628, COMPARED WITH THE ACTIVITY OF CIPROFLOXACIN AGAINST 5,252 CLINICAL BACTERIAL ISOLATES [J].
FUCHS, PC ;
BARRY, AL ;
PFALLER, MA ;
ALLEN, SD ;
GERLACH, EH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :764-766
[5]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITY OF AM-833, A NEW QUINOLONE DERIVATIVE [J].
HIRAI, K ;
AOYAMA, H ;
HOSAKA, M ;
OOMORI, Y ;
NIWATA, Y ;
SUZUE, S ;
IRIKURA, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) :1059-1066
[6]  
HOOPER DC, 1991, NEW ENGL J MED, V3244, P384
[8]   INTERPRETIVE CRITERIA FOR CI-960 (AM-1091, PD127391) DISK DIFFUSION TESTS USING 5-MU-G DISKS [J].
JONES, RN ;
ERWIN, ME ;
BARRETT, MS .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (04) :379-381
[9]  
JONES RN, 1995, IN PRESS DIAGNOSTIC
[10]   THE INVITRO ACTIVITY OF PD127,391, A NEW QUINOLONE [J].
KING, A ;
BOOTHMAN, C ;
PHILLIPS, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (02) :135-141